Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Fowler

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
The European Respiratory Journal|September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthmaJohn Busby, John G Matthews, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by SexMatthew C Eastwood, John Busby, David J Jackson, et al.
Journal of Breath Research|July 1, 2020
A benchmarking protocol for breath analysis: the peppermint experimentBen Henderson, Dorota M Ruszkiewicz, Max Wilkinson, et al.
Trials|January 6, 2018
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trialCatherine E Hanratty, John G Matthews, Joseph R Arron, et al.
The Journal of Allergy and Clinical Immunology|July 31, 2017
Pathway discovery using transcriptomic profiles in adult-onset severe asthmaPieter-Paul Hekking, Matt J Loza, Stelios Pavlidis, et al.
The European Respiratory Journal|September 29, 2017
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthmaPieter-Paul Hekking, Matthew J Loza, Stelios Pavlidis, et al.
The Lancet. Respiratory Medicine|September 11, 2020
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trialLiam G Heaney, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2020
eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopyMahmoud I Abdel-Aziz, Paul Brinkman, Susanne J H Vijverberg, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2019
IL-17-high asthma with features of a psoriasis immunophenotypeJörgen Östling, Marleen van Geest, James P R Schofield, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2016
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omicsDiane Lefaudeux, Bertrand De Meulder, Matthew J Loza, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
The European Respiratory Journal|September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthmaJohn Busby, John G Matthews, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by SexMatthew C Eastwood, John Busby, David J Jackson, et al.
Journal of Breath Research|July 1, 2020
A benchmarking protocol for breath analysis: the peppermint experimentBen Henderson, Dorota M Ruszkiewicz, Max Wilkinson, et al.
Trials|January 6, 2018
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trialCatherine E Hanratty, John G Matthews, Joseph R Arron, et al.
The Journal of Allergy and Clinical Immunology|July 31, 2017
Pathway discovery using transcriptomic profiles in adult-onset severe asthmaPieter-Paul Hekking, Matt J Loza, Stelios Pavlidis, et al.
The European Respiratory Journal|September 29, 2017
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthmaPieter-Paul Hekking, Matthew J Loza, Stelios Pavlidis, et al.
The Lancet. Respiratory Medicine|September 11, 2020
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trialLiam G Heaney, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2020
eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopyMahmoud I Abdel-Aziz, Paul Brinkman, Susanne J H Vijverberg, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2019
IL-17-high asthma with features of a psoriasis immunophenotypeJörgen Östling, Marleen van Geest, James P R Schofield, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2016
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omicsDiane Lefaudeux, Bertrand De Meulder, Matthew J Loza, et al.
Pageof 18